Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

NCT07732218 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Semaglutide (Ozempic®)

Sponsor

Rehman Medical Institute - RMI